These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37429270)

  • 21. Comparison of the effect of lemborexant with placebo and zolpidem tartrate extended release on sleep architecture in older adults with insomnia disorder.
    Moline M; Zammit G; Cheng JY; Perdomo C; Kumar D; Mayleben D
    J Clin Sleep Med; 2021 Jun; 17(6):1167-1174. PubMed ID: 33590823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles.
    Yadlapati R; Tye M; Keefer L; Kahrilas PJ; Pandolfino JE
    Am J Gastroenterol; 2018 Jan; 113(1):31-38. PubMed ID: 28895583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management.
    Gyawali CP; Tutuian R; Zerbib F; Rogers BD; Frazzoni M; Roman S; Savarino E; de Bortoli N; Vela MF; Sifrim D
    Gastroenterology; 2021 Nov; 161(5):1412-1422. PubMed ID: 34270955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict PPI response in GERD patients with extra esophageal symptoms.
    Ribolsi M; Guarino MPL; Tullio A; Cicala M
    Dig Liver Dis; 2020 Feb; 52(2):173-177. PubMed ID: 31623954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On-therapy impedance-pH monitoring can efficiently characterize PPI-refractory GERD and support treatment escalation.
    Frazzoni M; Frazzoni L; Ribolsi M; Russo S; Conigliaro R; De Bortoli N; Savarino E
    Neurogastroenterol Motil; 2023 May; 35(5):e14547. PubMed ID: 36780512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease.
    Park EY; Choi MG; Baeg M; Lim CH; Kim J; Cho Y; Park J; Lee I; Kim S; Choi K
    Dig Dis Sci; 2013 Oct; 58(10):2933-9. PubMed ID: 23765257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic values of GerdQ, 24-h ambulatory oesophageal pH and impedance-pH monitoring in Barrett's esophagus, reflux esophagitis and non-erosive reflux disease].
    Wang K; Duan LP; Ge Y; Xu ZJ; Xia ZW
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1228-32. PubMed ID: 21756791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
    Yadlapati R; Gyawali CP; Pandolfino JE;
    Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Mean Nocturnal Baseline Impedance and Post-Reflux Swallow-Induced Peristaltic Wave Index in the Diagnosis and Treatment of Gastroesophageal Reflux Disease.
    Liao S; Hao J; Zhou J; Cheng Y; Gao X; Wu Y; Cheng Y
    Dig Dis; 2023; 41(1):1-9. PubMed ID: 36349754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroesophageal reflux disease as an etiology of sleep disturbance in subjects with insomnia and minimal reflux symptoms: a pilot study of prevalence and response to therapy.
    Shaheen NJ; Madanick RD; Alattar M; Morgan DR; Davis PH; Galanko JA; Spacek MB; Vaughn BV
    Dig Dis Sci; 2008 Jun; 53(6):1493-9. PubMed ID: 17985241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overlap of functional heartburn and reflux hypersensitivity with proven gastroesophageal reflux disease.
    Rengarajan A; Pomarat M; Zerbib F; Gyawali CP
    Neurogastroenterol Motil; 2021 Jun; 33(6):e14056. PubMed ID: 33300667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reflux characteristics triggering post-reflux swallow-induced peristaltic wave (PSPW) in patients with GERD symptoms.
    Ribolsi M; Frazzoni M; De Bortoli N; Tolone S; Arsiè E; Mariani L; De Carlo G; Maniero D; Penagini R; Cicala M; Savarino E
    Neurogastroenterol Motil; 2022 Feb; 34(2):e14183. PubMed ID: 34051123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent insights on functional heartburn and reflux hypersensitivity.
    Savarino E; Marabotto E; Savarino V
    Curr Opin Gastroenterol; 2022 Jul; 38(4):417-422. PubMed ID: 35762702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.
    Triadafilopoulos G; Kamal A; Clarke JO
    Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36567531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
    Kindt S; Imschoot J; Tack J
    Dis Esophagus; 2011 Nov; 24(8):531-7. PubMed ID: 21418126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.
    Ribolsi M; Frazzoni M; Marabotto E; De Carlo G; Ziola S; Maniero D; Balestrieri P; Cicala M; Savarino E
    Aliment Pharmacol Ther; 2021 Aug; 54(4):412-418. PubMed ID: 34181753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of diagnosing gastroesophageal reflux disease by GerdQ, esophageal impedance monitoring and histology.
    Zhou LY; Wang Y; Lu JJ; Lin L; Cui RL; Zhang HJ; Xue Y; Ding SG; Lin SR
    J Dig Dis; 2014 May; 15(5):230-8. PubMed ID: 24528678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease.
    Visaggi P; Mariani L; Svizzero FB; Tarducci L; Sostilio A; Frazzoni M; Tolone S; Penagini R; Frazzoni L; Ceccarelli L; Savarino V; Bellini M; Gyawali PC; Savarino EV; de Bortoli N
    Esophagus; 2022 Oct; 19(4):525-534. PubMed ID: 35768671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exacerbation of gastroesophageal reflux symptoms after discontinuation of proton pump inhibitors is not associated with increased esophageal acid exposure.
    Hoshikawa Y; Nikaki K; Sonmez S; Nakagawa K; Yazaki E; Sifrim D; Woodland P
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13735. PubMed ID: 31657519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.